In vivo administration of recombinant BTNL2-Fc fusion protein ameliorates graft-versus-host disease in mice
Cui, Cheng, Tian, Xiaohong, Lin, Yujun, Su, Min, Chen, Qingquan, Wang, Shao-Yuan, Lai, LaijunLanguage:
english
Journal:
Cellular Immunology
DOI:
10.1016/j.cellimm.2018.10.008
Date:
October, 2018
File:
PDF, 1002 KB
english, 2018